Colorectal cancer in inflammatory bowel disease: Molecular and clinical features

Gastroenterology Clinics of North America

Volumn 31, Issue 2, 2002, Pages 551-564

  Murthy, Sreekant ^a   Flanigan, Anne ^a   Clearfield, Harris ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; FREE RADICAL; GROWTH FACTOR; INTEGRIN; MATRIX METALLOPROTEINASE;

CANCER EPIDEMIOLOGY; CANCER RISK; CARCINOGENESIS; CLINICAL FEATURE; COLORECTAL CANCER; CROHN DISEASE; DYSPLASIA; ENTERITIS; HUMAN; INFLAMMATION; NONHUMAN; REVIEW; RISK FACTOR; ULCERATIVE COLITIS; ANIMAL; ANIMAL MODEL; COLORECTAL TUMOR; GENETIC MARKER; GENETICS; HEALTH SURVEY; PATHOLOGY; PRECANCER; UNITED STATES;

ANIMAL; COLORECTAL NEOPLASMS; GENETIC MARKERS; HUMAN; INFLAMMATORY BOWEL DISEASES; MODELS, ANIMAL; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS; RISK FACTORS; UNITED STATES; ANIMALS; HUMANS;

EID: 0036314066     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(02)00014-6     Document Type: Review

References (60)

1. Prospects for research in inflammatory bowel disease
2. Inflammatory bowel disease: Progress toward a gene
3. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: Crohn's disease LP cells manifest increased secretion of IFN-gamma whereas ulcerative colitis LP cells manifest increased secretion of IL-5
4. Colorectal cancer prevention in ulcerative colitis: A case-control study
5. Intestinal cancer in patients with Crohn's disease: A population study in central Israel
6. Inflammatory bowel disease and colon cancer
7. Ulcerative colitis and colorectal cancer
8. The risk of colorectal cancer in ulcerative colitis. An epidemiologic study
9. Cancer in universal and left-sided ulcerative colitis
10. Dysplasia and cancer in inflammatory bowel disease
11. Dysplasia-associated lesions or mass (DALM) detected by colonoscopy in longstanding ulcerative colitis. An indication for colectomy
12. Villous dysplasia: An ominous histologic sign in colitis patients
13. The adenoma-carcinoma sequence
14. Benign intestinal neoplasms
15. Factors affecting the outcome of endoscopic surveillance for cancer and ulcerative colitis
16. Ulcerative colitis in colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia
17. Dysplasia in chronic ulcerative colitis. Implications for colonoscopic surveillance
18. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma
19. Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis
20. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions
21. Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis
22. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease
23. A proinflammatory cytokine inhibits p53 tumor suppressor activity
24. A genetic model for colorectal tumorigenesis
25. Genetic alterations in chronic ulcerative colitisassociated adenoma-like DALMs are similar to non-colitis sporadic adenomas
26. c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma
27. Comparative analysis of histology, DNA content p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis
28. c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis
29. Molecular screening of patients with long standing extensive ulcerative colitis: Detection of p53 and Ki-ras mutations by single strand conformation polymorphism analysis and differential hybridisation in colonic lavage fluid
30. A germline substitution in the human MSH2 gene is associated with high grade dysplasia and cancer in ulcerative colitis
31. Use of microsatellite marker in predicting dysplasia in ulcerative colitis
32. A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms
33. Hypermethylation of the pl6INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis
34. Accelerated age-related CpG island methylation in ulcerative colitis
35. p27 expression in inflammatory bowel diseaseassociated neoplasia: Further evidence of a unique molecular pathogenesis
36. The interactions of APC, E-cadherin and β-catenin in tumor development and progression
37. Expression of catenins in E-cadherins during epithelial restitution in inflammatory bowel disease
38. Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitisassociated dysplasia and carcinoma, as compared with sporadic colon neoplasms
39. Family history as a risk factor for ulcerative colitis-associated colon cancer in cotton top tamarin
40. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: A study of histopathology, β-catenin and p53 expression and the role of inflammation
41. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin
42. The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium induced colitis
43. Screening and surveillance colonoscopy in chronic Crohn's colitis
44. Ulcerative colitis and colorectal cancer
45. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval
46. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis
47. Risk factors of colorectal cancer in inflammatory bowel disease
48. Benign and malignant colorectal strictures in ulcerative colitis
49. Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy
50. Malignant colorectal strictures in Crohn's disease
51. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease
52. The risk of cancer and dysplasia among ulcerative coilitis patients with primary sclerosing cholangitis
53. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study
54. Family history as a risk factor for colorectal cancer in inflammatory bowel disease
55. Physician's perceptions of dysplasia and approaches to surveillance cdolonoscopy in ulcerative colitis
56. Surveying surveillance: Are gastroenterologists consistently inconsistent, inconsistently consistent, or poorly educated?
57. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?
58. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis
59. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: A clinical, pathological, and molecular review
60. Chromosomal alterations in ulcerative colitis-related neoplastic progression